Dun Wang
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 10
- Co-authors
- Yongjun Wang (10 shared papers)Jingling Tang (3 shared papers)Feng Liu (3 shared papers)Xiaoguang Yang (7 shared papers)Qiang Fu (2 shared papers)Zhonggui He (6 shared papers)Yuhua Wang (2 shared papers)Zhenghong Xu (1 shared paper)
- Journals
- ACS Applied Materials & Interfaces (3 papers)European Journal of Medicinal Chemistry (2 papers)International Journal of Pharmaceutics (2 papers)Annals of Palliative Medicine (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Dun Wang
32 papers receiving 538 citations
Peers
Comparison fields: 5 of 89
- Biomaterials 139
- Biomedical Engineering 197
- Pharmaceutical Science 23
- Oncology 90
- Physiology 13
Countries citing papers authored by Dun Wang
This map shows the geographic impact of Dun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dun Wang more than expected).
Fields of papers citing papers by Dun Wang
This network shows the impact of papers produced by Dun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dun Wang. The network helps show where Dun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 62 | |
| 2 | 2013 | 59 | |
| 3 | 2019 | 43 | |
| 4 | 2018 | 40 | |
| 5 | 2018 | 38 | |
| 6 | 2019 | 26 | |
| 7 | 2024 | 26 | |
| 8 | 2023 | 26 | |
| 9 | 2019 | 21 | |
| 10 | 2021 | 20 | |
| 11 | 2018 | 19 | |
| 12 | 2023 | 19 | |
| 13 | 2022 | 18 | |
| 14 | 2022 | 13 | |
| 15 | 2021 | 13 | |
| 16 | 2012 | 13 | |
| 17 | 2021 | 9 | |
| 18 | 2024 | 9 | |
| 19 | 2019 | 8 | |
| 20 | 2020 | 8 |
About Dun Wang
Dun Wang is a scholar working on Biomedical Engineering, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Biomaterials, having authored 35 papers that have together received 544 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Quinazolinone synthesis and applications (2 papers), Cancer Cells and Metastasis (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Biomaterials (139 citations), Biomedical Engineering (197 citations), Pharmaceutical Science (23 citations), Oncology (90 citations) and Physiology (13 citations). Dun Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yongjun Wang, Jingling Tang, Feng Liu, Xiaoguang Yang, Qiang Fu, Zhonggui He, Yuhua Wang, Zhenghong Xu, Haotian Zhang and Qiming Kan. Their work appears in journals such as ACS Applied Materials & Interfaces, European Journal of Medicinal Chemistry, International Journal of Pharmaceutics, Annals of Palliative Medicine and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.